|
|
Volumn 75, Issue 1, 2015, Pages 33-59
|
|
Pharmacodynamics, efficacy and safety of sodium-glucose co-transporter type 2 (SGLT2) inhibitors for the treatment of type 2 diabetes mellitus
a |
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
2-(3-(4-ETHOXYBENZYL)-4-CHLOROPHENYL)-6-HYDROXYMETHYLTETRAHYDRO-2H-PYRAN-3,4,5-TRIOL;
ANTIDIABETIC AGENT;
BENZHYDRYL DERIVATIVE;
CANAGLIFLOZIN;
EMPAGLIFLOZIN;
GLUCOSIDE;
IPRAGLIFLOZIN;
SLC5A2 PROTEIN, HUMAN;
SODIUM GLUCOSE COTRANSPORTER 2;
THIOPHENE DERIVATIVE;
ANTAGONISTS AND INHIBITORS;
DIABETES MELLITUS, TYPE 2;
HUMAN;
BENZHYDRYL COMPOUNDS;
DIABETES MELLITUS, TYPE 2;
GLUCOSIDES;
HUMANS;
HYPOGLYCEMIC AGENTS;
SODIUM-GLUCOSE TRANSPORTER 2;
THIOPHENES;
|
|
EID: 84923791994
PISSN: 00126667
EISSN: None
Source Type: Journal
DOI: 10.1007/s40265-014-0337-y Document Type: Review |
|
Times cited : (459)
|
|
References (0)
|